Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

NNVC

NanoViricides (NNVC)

NanoViricides Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NNVC
DateTimeSourceHeadlineSymbolCompany
01/27/20147:00AMBusiness WireNanoViricides Reports Construction of its New Facility & cGMP Pilot Production Plant is Nearing Completion, also Provides Det...AMEX:NNVCNanoViricides Inc
01/21/20149:16AMBusiness WireNanoViricides Announces that It Has Raised $20 Million in a Registered Direct OfferingAMEX:NNVCNanoViricides Inc
12/23/201312:17PMMarketwiredRecap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio InterviewAMEX:NNVCNanoViricides Inc
12/18/20139:27AMMarketwiredNanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AMAMEX:NNVCNanoViricides Inc
12/11/20138:52AMBusiness WireNanoViricides Announces that its Annual Meeting was held on December 9th, 2013; the CEO Presentation is available on the Rede...AMEX:NNVCNanoViricides Inc
12/02/20137:00AMBusiness WireNanoViricides, Inc. Reports Excellent Safety Profile of Its Broad-Spectrum anti-Influenza Drug Candidate, FluCide™ , in a N...AMEX:NNVCNanoViricides Inc
11/21/20132:37PMBusiness WireDengue Fever Case in New York Highlights Importance of NanoViricides’ DengueCide® Development ProgramAMEX:NNVCNanoViricides Inc
11/18/20137:00AMBusiness WireNanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Drug ...AMEX:NNVCNanoViricides Inc
11/11/20137:00AMBusiness WireNanoViricides Announces that DengueCide™ Has Received Orphan Drug Designation From the European Medicines Agency (EMA)AMEX:NNVCNanoViricides Inc
11/04/20137:00AMBusiness WireNanoViricides Announces Renewal of DengueCide™ Evaluation Contract with the Professor Eva Harris Laboratory at the Universi...AMEX:NNVCNanoViricides Inc
10/22/20134:45PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
10/21/20137:00AMBusiness WireNanoViricides Says Early Results Indicate that FluCide® Was Extremely Safe in a non-GLP Small Animal Tox StudyAMEX:NNVCNanoViricides Inc
10/08/201310:39AMEdgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:NNVCNanoViricides Inc
10/07/20137:00AMBusiness WireNanoViricides Announces Initiation of Toxicology Study of FluCide®AMEX:NNVCNanoViricides Inc
10/02/20137:00AMBusiness WireNanoviricides, Inc. Announces That Its CEO, Eugene Seymour, MD, MPH will Present at LD MICRO Invitational on October 2nd in W...AMEX:NNVCNanoViricides Inc
10/01/20137:00AMBusiness WireNanoViricides Files Annual Report - Reports Having Sufficient Funds to Advance A Drug Candidate into Clinical TrialsAMEX:NNVCNanoViricides Inc
09/25/20139:35AMBusiness WireNanoViricides Begins Trading on NYSE MKT National Exchange; CEO Dr Seymour Invited to Speak at Duke University’s Fuqua Bus....AMEX:NNVCNanoViricides Inc
09/23/20137:00AMBusiness WireNanoViricides to List Common Stock on New York Stock Exchange MKT; Company Stock Symbol Will Remain NNVCAMEX:NNVCNanoViricides Inc
03/28/20068:00AMPR Newswire (US)NanoViricides, Inc. President Featured in Exclusive Interview With WallSt.netAMEX:NNVC
 Showing the most relevant articles for your search:AMEX:NNVC